Global Radiotheranostics Market Report to 2027 – Featuring TransCode Therapeutics, Curium SAS, GE Healthcare and Bayer Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Radiotheranostics Market by Radioisotope, Application, End-user and Region: Competition Forecast and Opportunities to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global radiotheranostics market is anticipated to register growth at an impressive CAGR in the forecast period, 2023-2027. Radiotheranostics is a process that involves the use of radionuclides for paired imaging … [Read more…]

NOV 2: NEW Hepatology Research Unveiled during Virtual Press Pre-Brief for The Liver Meeting®

Zoom Press Event in Advance of Nov 4-8 Conference –(BUSINESS WIRE)–#AASLD—  WHAT To highlight newest cutting-edge research on liver disease, the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting® (TLM®) will hold a virtual news conference Wednesday, November 2 at 12noon Eastern. The news briefing features four experts discussing their conference … [Read more…]

Mass General Brigham Implements DexCare to Support Care Integration and Advance Digital Health

Collaboration demonstrates Mass General Brigham’s commitment to digital transformation and enhancing patient experience SEATTLE–(BUSINESS WIRE)–DexCare, Inc., a data-driven intelligence company focused on healthcare access, and Mass General Brigham, an integrated academic health care system, today announced that Mass General Brigham has implemented DexCare’s Platform-as-a-Service (PaaS) for an end-to-end digital consumer experience and to aim for … [Read more…]

ZOLL Awarded Diagnostic and Interventional Cardiology Catheter Agreement with Premier, Inc. for TherOx SuperSaturated Oxygen Therapy

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated Oxygen (SSO2) Therapy has been awarded a group purchasing agreement for Diagnostic and Interventional Cardiology Catheters (DIC) with Premier, Inc., effective as of July 1, 2022. The agreement allows Premier hospital members, at their … [Read more…]

Cleveland Diagnostics Announces the Publication of Two Major IsoPSA® Studies

Prospective, multicenter clinical validation study and retrospective real-world outcomes study reaffirm significant improvement over standard of care tests and overall utility of IsoPSA in the detection of prostate cancer CLEVELAND–(BUSINESS WIRE)–Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today the publication of two additional major … [Read more…]

Sagimet Biosciences Announces Late-Breaking, Oral and Poster Presentations for Denifanstat (TVB-2640), a First-in-Class Fatty Acid Synthase Inhibitor, in NASH at AASLD’s The Liver Meeting

Additional Preclinical Data on Denifanstat Published in Scientific Reports SAN MATEO, Calif.–(BUSINESS WIRE)–#Clinicaltrials–Sagimet Biosciences, a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, announced today that it will present three abstracts at The Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4-8, 2022, in Washington, … [Read more…]

Global Peripheral Neuropathy Market Report 2022: High Prevalence of Chronic Neuropathic Pain Fuels Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030” report has been added to ResearchAndMarkets.com’s offering. General population studies have reported that 7 to 8% adults currently have chronic neuropathic pain, where the reported incidence is of 8 cases per 1,000 … [Read more…]

Cognito Therapeutics to Present Clinical Data Evaluating Gamma Frequency Neuromodulation in Alzheimer’s Disease at 2022 CTAD Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#CTAD2022—Cognito Therapeutics, a clinical-stage company pioneering disease-modifying therapeutic interventions for neurodegenerative diseases, announced today it has been selected to present clinical data from its proprietary gamma sensory stimulation in patients with Alzheimer’s Disease, at the 2022 Clinical Trials in Alzheimer’s Disease (CTAD), held November 29 – December 2, in San Francisco, CA. “We’re … [Read more…]

Altoida to Present at Upcoming Industry Conferences

WASHINGTON–(BUSINESS WIRE)–#AR—Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that management will be presenting at the upcoming conferences: BioFuture Panel Title: New Diagnostics: Revolutionizing Care in Alzheimer’s Date/Time: Wednesday, Nov. 9, 10:30 – 11:30 am ET Location: Lotte Palace Hotel, … [Read more…]

The Institute of Food Technologists and Seeding The Future Foundation Announce Seed Grant Winners, Finalists for Growth Grants and Grand Prizes for Seeding The Future Global Food System Challenge

CHICAGO–(BUSINESS WIRE)–The Institute of Food Technologists (IFT) and Seeding The Future Foundation today announced the Seed Grant winners and finalists for Growth Grants and Grand Prizes of the Seeding The Future Global Food System Challenge. Out of over 600 application submissions from 75 countries, eight organizations were selected to receive Seed Grants and 11 finalists … [Read more…]